DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

PURPOSE: The combination of systemic cisplatin with local and regional radiotherapy as primary treatment of head and neck squamous cell carcinoma (HNSCC) leads to cure in approximately half of the patients. The addition of cisplatin has significant effects on outcome, but despite extensive research...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens-de Kemp, Sanne R., Dalm, Simone U., Wijnolts, Fiona M. J., Brink, Arjen, Honeywell, Richard J., Peters, Godefridus J., Braakhuis, Boudewijn J. M., Brakenhoff, Ruud H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629194/
https://www.ncbi.nlm.nih.gov/pubmed/23613873
http://dx.doi.org/10.1371/journal.pone.0061555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629194/
https://www.ncbi.nlm.nih.gov/pubmed/23613873
http://dx.doi.org/10.1371/journal.pone.0061555

Ejemplares similares